ImmunityBio Inc. (IBRX)
2.96
-0.05 (-1.66%)
At close: Apr 01, 2025, 3:59 PM
2.99
0.98%
After-hours: Apr 01, 2025, 07:58 PM EDT
ImmunityBio Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Cash & Equivalents | 143.43M | 265.45M | 104.64M | 181.1M | 34.91M | 15.51M | 16.82M | 23.87M | 8.08M | 175.91M | 59.1M | 350K |
| Short-Term Investments | 6.38M | 1.01M | 2.54M | 136.01M | 61.15M | 36.14M | 57.33M | 104.28M | 190.84M | 118.31M | n/a | n/a |
| Long-Term Investments | n/a | 891K | 5.7M | 6.78M | 10.45M | 10.93M | 14.38M | 38.28M | 87.75M | 55.13M | n/a | n/a |
| Other Long-Term Assets | 11.96M | 9.7M | 6.63M | 7.2M | 3.34M | -11.1M | -1.67M | 151K | 137K | 344K | 409K | 249K |
| Receivables | 2.36M | 3.17M | 1.89M | 1.33M | n/a | 303K | 12.17M | 1.26M | n/a | 1.77M | 145K | 380K |
| Inventory | 8.27M | n/a | 26.35M | n/a | n/a | n/a | n/a | 1.00 | n/a | n/a | n/a | n/a |
| Other Current Assets | 24.14M | 5.21M | 5.15M | 5.55M | n/a | 24K | 42K | 880K | 662K | n/a | n/a | 248K |
| Total Current Assets | 184.59M | 294.08M | 140.58M | 334.35M | 111.71M | 55.76M | 88.77M | 132.46M | 205.15M | 297.54M | 59.37M | 978K |
| Property-Plant & Equipment | 170.46M | 182.68M | 189.45M | 119.17M | 90.68M | 72.23M | 76.89M | 76.73M | 19.27M | 6.15M | 211K | 13K |
| Goodwill & Intangibles | 15.93M | 17.09M | 20M | 1.42M | 1.46M | 12.07M | 12.09M | 2.83M | 5.09M | 7.29M | 835K | 863K |
| Total Long-Term Assets | 198.35M | 210.37M | 221.78M | 134.56M | 109.67M | 87.37M | 93.18M | 117.98M | 112.35M | 69.31M | 1.46M | 1.13M |
| Total Assets | 382.93M | 504.45M | 362.36M | 468.91M | 221.38M | 143.12M | 181.95M | 250.44M | 317.5M | 366.85M | 60.83M | 2.1M |
| Account Payables | 6.72M | 9.2M | 21.02M | 11.42M | 11.51M | 1.75M | 2.79M | 5.87M | 4.04M | 2.08M | 1.13M | 1.5M |
| Deferred Revenue | n/a | n/a | 100K | n/a | n/a | n/a | n/a | 520K | 197K | 228K | 521K | 573K |
| Short-Term Debt | 7.47M | n/a | 431.9M | 302.25M | n/a | 3.96M | 965K | 618K | 534K | -228K | 265K | 1.76M |
| Other Current Liabilities | 33.29M | 18.31M | 19.74M | 46.71M | 18M | 5.85M | 23.5M | 13.87M | 7.78M | 4.06M | -33K | -1.19M |
| Total Current Liabilities | 54.94M | 58.28M | 500.86M | 369M | 68.13M | 11.56M | 27.26M | 20.87M | 12.55M | 6.15M | 2.4M | 5M |
| Long-Term Debt | 34.82M | 681.54M | 241.27M | 343.42M | 254.35M | 10.88M | n/a | n/a | n/a | 2.47M | n/a | n/a |
| Other Long-Term Liabilities | 781.29M | 310.63M | 22.09M | -36.82M | 1.21M | -10.88M | 2.74M | 3.41M | 2.67M | -1.4M | 521K | 2.35M |
| Total Long-Term Liabilities | 816.12M | 1.03B | 311.31M | 343.83M | 271.74M | 10.88M | 8.68M | 10.73M | 11.52M | 4.71M | 1.92M | 3.83M |
| Total Liabilities | 871.06M | 1.09B | 812.18M | 712.82M | 339.87M | 22.44M | 35.94M | 31.6M | 24.08M | 10.85M | 2.4M | 5M |
| Total Debt | 42.29M | 726.72M | 723.77M | 645.66M | 275.55M | 14.85M | 6.91M | 7.27M | 8.21M | 2.47M | 265K | 1.76M |
| Common Stock | 85K | 67K | 42K | 40K | 38K | 10K | 8K | 8K | 8K | 8K | 3K | 2K |
| Retained Earnings | -3.38B | -2.96B | -2.38B | -1.96B | -1.62B | -662.19M | -594.98M | -498.71M | -387.06M | -250.38M | -12.74M | -6.53M |
| Comprehensive Income | 1.2M | 10K | 183K | 4K | 122K | -105K | -267K | -381K | -284K | -192K | -46K | -9K |
| Shareholders Equity | -488.13M | -586.99M | -447.33M | -242.17M | -119.81M | 120.68M | 146.01M | 218.84M | 293.42M | 356M | 58.42M | -2.9M |
| Total Investments | 6.38M | 1.9M | 8.24M | 142.79M | 71.59M | 47.07M | 71.71M | 142.56M | 278.59M | 173.44M | n/a | n/a |